We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-13.99%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$18.4B
AUM Growth
–
Cap. Flow
+$19.9B
Cap. Flow
% of AUM
108.64%
Top 10 Holdings %
Top 10 Hldgs %
28.05%
Holding
651
New
651
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GG
Goldcorp Inc
GG
|
+$1.05B |
| 2 |
B
Barrick Mining
B
|
+$803M |
| 3 |
Newmont
NEM
|
+$803M |
| 4 |
SLB Ltd
SLB
|
+$596M |
| 5 |
GOLD
Randgold Resources Ltd
GOLD
|
+$496M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 45.24% |
| 2 | Energy | 26.06% |
| 3 | Industrials | 5.86% |
| 4 | Consumer Staples | 4.48% |
| 5 | Healthcare | 2.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARMH
151
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $11.6M | 0.06% |
+320,883
| New | +$13.8M |
|
152
Bristol-Myers Squibb
BMY
$129B
| $11.6M | 0.06% |
+258,445
| New | +$11.2M |
|
153
Franklin Resources
BEN
$16.8B
| $11.5M | 0.06% |
+252,888
| New | +$12.9M |
|
|
JOY
154
DELISTED
Joy Global Inc
JOY
| $11.4M | 0.06% |
+234,845
| New | +$12.9M |
|
155
Green Plains
GPRE
$1.15B
| $11.3M | 0.06% |
+851,700
| New | +$11.3M |
|
156
Vista Gold
VGZ
$250M
| $11.3M | 0.06% |
+11,610,354
| New | +$17M |
|
157
Applied Materials
AMAT
$347B
| $11.1M | 0.06% |
+746,989
| New | +$10.8M |
|
158
Oracle
ORCL
$339B
| $11.1M | 0.06% |
+362,038
| New | +$12M |
|
159
Vulcan Materials
VMC
$36.8B
| $11M | 0.06% |
+227,559
| New | +$11.7M |
|
160
Analog Devices
ADI
$172B
| $11M | 0.06% |
+243,526
| New | +$11M |
|
|
QGENF
161
DELISTED
QIAGEN NV
QGENF
| $11M | 0.06% |
+550,979
| New | +$11M |
|
|
PCYC
162
DELISTED
PHARMACYCLICS INC
PCYC
| $10.9M | 0.06% |
+136,727
| New | +$11.2M |
|
163
Teva Pharmaceuticals
TEVA
$40.4B
| $10.9M | 0.06% |
+277,180
| New | +$10.8M |
|
164
Paramount Gold Nevada
PZG
$90.9M
| $10.7M | 0.06% |
+9,026,688
| New | +$13.7M |
|
165
AbbVie
ABBV
$465B
| $10.5M | 0.06% |
+253,266
| New | +$11.1M |
|
166
Abbott
ABT
$188B
| $10.4M | 0.06% |
+297,262
| New | +$10.9M |
|
167
Eli Lilly
LLY
$1.08T
| $10.3M | 0.06% |
+209,197
| New | +$11.4M |
|
168
AstraZeneca
AZN
$269B
| $10.1M | 0.05% |
+212,480
| New | +$10.8M |
|
|
NVO
169
Novo Nordisk
NVO
$228B
| $10M | 0.05% |
+645,740
| New | +$10.7M |
|
170
Bausch Health
BHC
$1.75B
| $9.62M | 0.05% |
+111,702
| New | +$8.8M |
|
|
BTU
171
DELISTED
PEABODY ENERGY CORP COM STK NEW (DE)
BTU
| $9.32M | 0.05% |
+42,433
| New | +$12.2M |
|
|
AGN
172
DELISTED
Allergan Inc
AGN
| $9.1M | 0.05% |
+108,063
| New | +$11.2M |
|
|
CRR
173
DELISTED
Carbo Ceramics Inc.
CRR
| $9.05M | 0.05% |
+134,186
| New | +$9.94M |
|
|
CQB
174
DELISTED
CHIQUITA BRANDS INTL (NEW)
CQB
| $8.84M | 0.05% |
+809,115
| New | +$7.49M |
|
|
ALTR
175
DELISTED
Altera Corp
ALTR
| $8.51M | 0.05% |
+258,016
| New | +$8.46M |
|
Similar funds
DAM
VanEck Associates's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for VanEck Associates, which disclosed 651 positions worth $18.4B. Its ten largest holdings account for 28% of the portfolio.
Its largest position is Goldcorp Inc: 37,142,019 shares worth $919M.
By sector, the portfolio is most concentrated in Materials at 45% of assets, followed by Energy and Industrials.
- VanEck Associates's largest Q2 2013 buy was Goldcorp Inc: 37,142,019 shares worth $919M.
- VanEck Associates's ten largest holdings make up 28% of its $18.4B portfolio in Q2 2013.
- VanEck Associates disclosed 651 positions in Q2 2013, its first 13F filing on record.
Based on VanEck Associates's 13F filing for Q2 2013, filed 14 Aug 2013.